Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis
Background: Gastric cancer is the third leading cause of cancer-related death worldwide, for which several novel therapeutic strategies have been developed. Cisplatin (CDDP) mainly exerts its anti-gastric cancer effects; however, drug resistance limits its use. Thus, the development of drugs that ca...
| Published in: | Heliyon |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-11-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023083184 |